Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Revenue: 2021-2022

Historic Revenue for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to -$10.1 million.

  • Cardiol Therapeutics' Revenue fell 25.54% to -$10.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$35.5 million, marking a year-over-year change of. This contributed to the annual value of $62,847 for FY2021, which is 100.41% up from last year.
  • Cardiol Therapeutics' Revenue amounted to -$10.1 million in Q3 2022, which was down 39.98% from -$7.2 million recorded in Q2 2022.
  • In the past 5 years, Cardiol Therapeutics' Revenue registered a high of -$5.2 million during Q2 2021, and its lowest value of -$10.4 million during Q4 2021.
  • Over the past 2 years, Cardiol Therapeutics' median Revenue value was -$7.7 million (recorded in 2022), while the average stood at -$8.0 million.
  • Data for Cardiol Therapeutics' Revenue shows a maximum YoY slumped of 38.57% (in 2022) over the last 5 years.
  • Over the past 2 years, Cardiol Therapeutics' Revenue (Quarterly) stood at -$10.4 million in 2021, then declined by 25.54% to -$10.1 million in 2022.
  • Its Revenue was -$10.1 million in Q3 2022, compared to -$7.2 million in Q2 2022 and -$7.7 million in Q1 2022.